Get the Stockscreener App
93.47
0.19%
-0.18
Pre-market:
93.50
0.03
+0.03%
Spdr Biotech Etf stock is traded at $93.47, with a volume of 7.79M.
It is down -0.19% in the last 24 hours and up +7.66% over the past month.
See More
Previous Close:
$93.65
Open:
$93.59
24h Volume:
7.79M
Relative Volume:
0.81
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.52%
1M Performance:
+7.66%
6M Performance:
+8.52%
1Y Performance:
-5.13%
1-Day Range:
$92.49
$93.97
1-Week Range:
$89.33
$94.86
52-Week Range:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
93.47 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
320.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
649.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
652.21 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
575.23 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Stock (XBI) Latest News
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
(XBI) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
Liquidity Mapping Around (XBI) Price Events - news.stocktradersdaily.com
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
How (XBI) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
XBI ETF Implied Analyst Target Price: $139.15 per unit, with 54.74% upside from current price of $89.92 per unit. - AInvest
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Noteworthy ETF Inflows: XBI, ALNY, HALO, INSM - Nasdaq
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
(XBI) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
Exploring the SPDR S&P Biotech ETF (XBI) for Biotech Industry Exposure - AInvest
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Assessing the Political and Policy Risks in the 2028 U.S. Presidential Race and Their Impact on Health and Biotech Sectors - AInvest
Health and Human Services Secretary Robert F. Kennedy Jr. Disavows 2028 Presidential Run, Pledges Loyalty to Trump. - AInvest
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
7 Best Biotech ETFs to Buy Now - US News Money
ETF Talk: Create the Future with This ETF - Stock Investor
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF - Nasdaq
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 of the Best AI ETFs to Buy for 2025 - US News Money
Prasad’s FDA Return Adds to Leadership Turmoil at U.S. Health Agencies - Barron's
FDA Leadership Shifts and Their Impact on Biotech Valuations: Navigating Regulatory Risk in the Post-Vinay Prasad Era - AInvest
Regulatory Leadership Volatility: How FDA Reinstatements Reshape Biotech Investment Landscapes - AInvest
The AI-Driven Medtech Revolution: Why Heartflow's IPO Signals a Strategic Buy in a Shifting Market - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
QQQ Tops Daily ETF Inflows - ETF.com
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
The World’s First AI Genome Editor - Brownstone Research
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
(08/04/25) BBH: A Biotech Fund That’s Ripe for a Major Turnaround - moneyshow.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Growth in Short Interest - Defense World
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):